Nanoviricides Inc (NNVC)
1.16
+0.03
(+2.65%)
USD |
NYAM |
Mar 28, 16:00
1.175
+0.02
(+1.29%)
After-Hours: 20:00
Nanoviricides Total Assets (Quarterly): 13.40M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 13.40M |
September 30, 2023 | 15.42M |
June 30, 2023 | 16.90M |
March 31, 2023 | 18.58M |
December 31, 2022 | 20.34M |
September 30, 2022 | 22.08M |
June 30, 2022 | 23.49M |
March 31, 2022 | 25.14M |
December 31, 2021 | 26.81M |
September 30, 2021 | 29.18M |
June 30, 2021 | 30.26M |
March 31, 2021 | 32.76M |
December 31, 2020 | 28.09M |
September 30, 2020 | 31.85M |
June 30, 2020 | 23.91M |
March 31, 2020 | 16.53M |
December 31, 2019 | 11.62M |
September 30, 2019 | 11.79M |
June 30, 2019 | 13.45M |
March 31, 2019 | 15.39M |
December 31, 2018 | 15.00M |
September 30, 2018 | 17.37M |
June 30, 2018 | 18.55M |
March 31, 2018 | 22.34M |
December 31, 2017 | 23.73M |
Date | Value |
---|---|
September 30, 2017 | 25.27M |
June 30, 2017 | 27.00M |
March 31, 2017 | 28.58M |
December 31, 2016 | 31.36M |
September 30, 2016 | 34.22M |
June 30, 2016 | 36.63M |
March 31, 2016 | 38.32M |
December 31, 2015 | 40.85M |
September 30, 2015 | 42.30M |
June 30, 2015 | 44.19M |
March 31, 2015 | 45.60M |
December 31, 2014 | 47.60M |
September 30, 2014 | 49.02M |
June 30, 2014 | 43.86M |
March 31, 2014 | 40.95M |
December 31, 2013 | 22.89M |
September 30, 2013 | 25.11M |
June 30, 2013 | 16.41M |
March 31, 2013 | 17.88M |
December 31, 2012 | 15.61M |
September 30, 2012 | 14.35M |
June 30, 2012 | 15.63M |
March 31, 2012 | 14.38M |
December 31, 2011 | 13.56M |
September 30, 2011 | 12.38M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
11.62M
Minimum
Dec 2019
32.76M
Maximum
Mar 2021
21.35M
Average
21.21M
Median
Total Assets (Quarterly) Benchmarks
Gilead Sciences Inc | 62.12B |
NovaBay Pharmaceuticals Inc | 12.85M |
Palatin Technologies Inc | 13.55M |
iBio Inc | 34.02M |
Theriva Biologics Inc | 55.22M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 0.9511M |
Shareholders Equity (Quarterly) | 12.45M |